FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2492534498> ?p ?o ?g. }

• W2492534498 abstract "The aim was to estimate the impact of individual risk factors and treatment with various disease-modifying antirheumatic drugs (DMARDs) on the incidence of myocardial infarction (MI) in patients with rheumatoid arthritis (RA). We analysed data from 11,285 patients with RA, enrolled in the prospective cohort study RABBIT, at the start of biologic (b) or conventional synthetic (cs) DMARDs. A nested case–control study was conducted, defining patients with MI during follow-up as cases. Cases were matched 1:1 to control patients based on age, sex, year of enrolment and five cardiovascular (CV) comorbidities. Generalized linear models were applied (Poisson regression with a random component, conditional logistic regression). In total, 112 patients developed an MI during follow-up. At baseline, during the first 6 months of follow-up and prior to the MI, inflammation markers (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) but not 28-joint-count disease activity score (DAS28) were significantly higher in MI cases compared to matched controls and the remaining cohort. Baseline treatment with DMARDs was similar across all groups. During follow-up bDMARD treatment was significantly more often discontinued or switched in MI cases. CV comorbidities were significantly less often treated in MI cases vs. matched controls (36 % vs. 17 %, p < 0.01). In the adjusted regression model, we found a strong association between higher CRP and MI (OR for log-transformed CRP at follow-up: 1.47, 95 % CI 1.00; 2.16). Furthermore, treatment with prednisone ≥10 mg/day (OR 1.93, 95 % CI 0.57; 5.85), TNF inhibitors (OR 0.91, 95 % CI 0.40; 2.10) or other bDMARDs (OR 0.85, 95 % CI 0.27; 2.72) was not associated with higher MI risk. CRP was associated with risk of MI. Our results underline the importance of tight disease control taking not only global disease activity, but also CRP as an individual marker into account. It seems irrelevant with which class of (biologic or conventional) DMARD effective control of disease activity is achieved. However, in some patients the available treatment options were insufficient or insufficiently used - regarding DMARDs to treat RA as well as regarding the treatment of CV comorbidities." @default.
• W2492534498 created "2016-08-23" @default.
• W2492534498 creator A5025815003 @default.
• W2492534498 creator A5026734298 @default.
• W2492534498 creator A5032375376 @default.
• W2492534498 creator A5044290696 @default.
• W2492534498 creator A5051747280 @default.
• W2492534498 creator A5063937523 @default.
• W2492534498 creator A5065106667 @default.
• W2492534498 creator A5066074125 @default.
• W2492534498 creator A5071732733 @default.
• W2492534498 creator A5082232958 @default.
• W2492534498 date "2016-08-05" @default.
• W2492534498 modified "2023-10-15" @default.
• W2492534498 title "Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis" @default.
• W2492534498 cites W1528319505 @default.
• W2492534498 cites W1812416290 @default.
• W2492534498 cites W1899262884 @default.
• W2492534498 cites W1926338667 @default.
• W2492534498 cites W1977476168 @default.
• W2492534498 cites W1991752817 @default.
• W2492534498 cites W1996591784 @default.
• W2492534498 cites W2011322417 @default.
• W2492534498 cites W2026730648 @default.
• W2492534498 cites W2032485049 @default.
• W2492534498 cites W2033538734 @default.
• W2492534498 cites W2037882607 @default.
• W2492534498 cites W2038772512 @default.
• W2492534498 cites W2051104073 @default.
• W2492534498 cites W2072117604 @default.
• W2492534498 cites W2075619622 @default.
• W2492534498 cites W2075994714 @default.
• W2492534498 cites W2096178422 @default.
• W2492534498 cites W2096809109 @default.
• W2492534498 cites W2096899692 @default.
• W2492534498 cites W2100001424 @default.
• W2492534498 cites W2107171194 @default.
• W2492534498 cites W2108006070 @default.
• W2492534498 cites W2110826367 @default.
• W2492534498 cites W2114270885 @default.
• W2492534498 cites W2122771444 @default.
• W2492534498 cites W2137499656 @default.
• W2492534498 cites W2139765430 @default.
• W2492534498 cites W2141525967 @default.
• W2492534498 cites W2143727405 @default.
• W2492534498 cites W2158291913 @default.
• W2492534498 cites W2166242552 @default.
• W2492534498 cites W2166493208 @default.
• W2492534498 cites W2167280850 @default.
• W2492534498 cites W2167939282 @default.
• W2492534498 cites W2170108033 @default.
• W2492534498 cites W2279146469 @default.
• W2492534498 cites W2316306290 @default.
• W2492534498 cites W2322234778 @default.
• W2492534498 cites W48282725 @default.
• W2492534498 cites W64169420 @default.
• W2492534498 doi "https://doi.org/10.1186/s13075-016-1077-z" @default.
• W2492534498 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4975917" @default.
• W2492534498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27495156" @default.
• W2492534498 hasPublicationYear "2016" @default.
• W2492534498 type Work @default.
• W2492534498 sameAs 2492534498 @default.
• W2492534498 citedByCount "46" @default.
• W2492534498 countsByYear W24925344982016 @default.
• W2492534498 countsByYear W24925344982017 @default.
• W2492534498 countsByYear W24925344982018 @default.
• W2492534498 countsByYear W24925344982019 @default.
• W2492534498 countsByYear W24925344982020 @default.
• W2492534498 countsByYear W24925344982021 @default.
• W2492534498 countsByYear W24925344982022 @default.
• W2492534498 countsByYear W24925344982023 @default.
• W2492534498 crossrefType "journal-article" @default.
• W2492534498 hasAuthorship W2492534498A5025815003 @default.
• W2492534498 hasAuthorship W2492534498A5026734298 @default.
• W2492534498 hasAuthorship W2492534498A5032375376 @default.
• W2492534498 hasAuthorship W2492534498A5044290696 @default.
• W2492534498 hasAuthorship W2492534498A5051747280 @default.
• W2492534498 hasAuthorship W2492534498A5063937523 @default.
• W2492534498 hasAuthorship W2492534498A5065106667 @default.
• W2492534498 hasAuthorship W2492534498A5066074125 @default.
• W2492534498 hasAuthorship W2492534498A5071732733 @default.
• W2492534498 hasAuthorship W2492534498A5082232958 @default.
• W2492534498 hasBestOaLocation W24925344981 @default.
• W2492534498 hasConcept C120665830 @default.
• W2492534498 hasConcept C121332964 @default.
• W2492534498 hasConcept C126322002 @default.
• W2492534498 hasConcept C151956035 @default.
• W2492534498 hasConcept C198451711 @default.
• W2492534498 hasConcept C2776914184 @default.
• W2492534498 hasConcept C2777575956 @default.
• W2492534498 hasConcept C2778143017 @default.
• W2492534498 hasConcept C2778720950 @default.
• W2492534498 hasConcept C2781195455 @default.
• W2492534498 hasConcept C2908647359 @default.
• W2492534498 hasConcept C500558357 @default.
• W2492534498 hasConcept C61511704 @default.
• W2492534498 hasConcept C71924100 @default.
• W2492534498 hasConcept C72563966 @default.
• W2492534498 hasConcept C73269764 @default.
• W2492534498 hasConcept C99454951 @default.

• next